University of Rochester

This Week in PNAS

In PNAS this week: effector proteins contributing to Legionnaires' disease virulence, proteomic analysis of transition to quiescence, and more.

The study will use Admera's PGxOne Plus test, which uses next-generation sequencing technology to interrogate genes in order to predict how patients will respond to drug therapy.

In Genome Research this week: repetitive satellite DNA in the fruit fly, transcriptome map assembly pipeline, and more.

The semifinalists will receive $50,000 each to develop prototypes of their concepts for submission in the second phase of the challenge.

The medical center will provide samples from their patients and will have access to the company's clinical data and other biological samples.

The optimal statistical method to find differences in methylation between case samples and control samples depends on the study's sample size.

NEW YORK (GenomeWeb) — Spurred by evidence that PCR of sputum, in addition to commonly tested nasal and pharyngeal swabs, can allow more sensitive diagnosis of respiratory viruses, researchers from the University of Rochester have published a study demonstrating their method for processing sputum

NEW YORK (GenomeWeb) – The University of Rochester has received a $4 million donation from the James P. Wilmot Foundation to fund the recruitment of a senior researcher in cancer genomics and to cover startup costs for the scientist's lab.

NEW YORK (GenomeWeb News) – While variants in the gene FTO have previously been associated with a propensity toward obesity, the University of Chicago's Marcelo Nóbrega and colleagues reported in Nature this week that those obesity-linked variants in FTO actually

The University of Rochester of Rochester, NY, has received US Patent No.

Pages

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.